ArticleGeriatrics & gerontology international2026
Associations Between Serum N-Terminal Pro-Brain Natriuretic Peptide Levels and the Prevalence of Sarcopenia in Middle-Aged and Older Japanese Adults: A Population-Based Cross-Sectional Study.
Article in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Associations Between Serum N-Terminal Pro-Brain Natriuretic Peptide Levels and the Prevalence of Sarcopenia in Middle-Aged and Older Japanese Adults: A Population-Based Cross-Sectional Study.Geriatrics & gerontology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
aimEvidence regarding the association between heart failure and sarcopenia in middle-aged and older community-dwelling adults is scarce. This study aimed to examine the association between NT-proBNP levels and sarcopenia among community-dwelling adults aged 40-74 years.
methodsThis cross-sectional study was conducted based on the Circulatory Risk in Communities Study, which involved 1675 Japanese residents aged 40-74 years. Serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, physical function, and lifestyle information were measured. Participants were categorized according to their NT-proBNP levels (< 55, 55-124, and ≥ 125 pg/mL). Multivariate-adjusted logistic regression models were used to calculate the odds ratios for low skeletal muscle mass, muscle strength, walking speed, maximal walking speed, and sarcopenia according to serum NT-proBNP levels.
resultsAmong the analyzed participants, the prevalence was 22.6% for low skeletal muscle mass, 4.3% for low handgrip strength, 14.3% for low walking speed, 24.1% for low maximal walking speed, and 5.9% for sarcopenia. The multivariable odds ratios (95% confidence interval, p for trend) comparing the highest versus lowest groups of serum NT-proBNP levels were 1.63 (1.07-2.49, p < 0.01) for low skeletal muscle mass, 3.38 (1.70-6.73, p < 0.01) for low handgrip strength, 1.81 (0.96-3.40, p = 0.06) for low walking speed, 1.75 (1.03-2.97, p = 0.06) for low maximal walking speed, and 2.56 (1.07-6.14, p = 0.03) for sarcopenia.
conclusionsHigh serum NT-proBNP levels, which are a surrogate marker for heart failure, were associated with low physical function and sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.